CD24 and cancer: Fluorescence-activated cell sorting (FACS) using CD44 and CD24 as markers revealed that HMLE-EMT cultures likewise contained a distinct subpopulation of cells carrying the CD44+CD24low/− antigenic phenotype associated with so-called mesenchymal cancer stem cells (CSC) [62,63].